Jaydess

Levonorgestrel, the active ingredient in Jaydess, is a progestin presented as a 13.5 mg intrauterine system for intrauterine use. It prevents pregnancy and can be used to treat heavy menstrual bleeding in women of reproductive age.

GNH USA supplies Jaydess as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jaydess is a hormonal intrauterine system that acts on the reproductive endocrine pathway to provide contraception and manage menstrual disorders.

Contraception: offers highly effective, reversible birth control for up to three years. Heavy menstrual bleeding: reduces menstrual blood loss and improves bleeding patterns. Endometrial protection: maintains a thin, stable endometrium, decreasing the risk of hyperplasia.

Jaydess may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Irregular vaginal bleeding or spotting - Amenorrhea (absence of periods) - Pelvic or abdominal discomfort - Headache or breast tenderness - Mood changes or acne - Weight gain or fluid retention

Serious or Rare Side Effects: - Uterine perforation during insertion - Device expulsion or displacement - Pelvic inflammatory infection - Ectopic pregnancy if contraception fails - Severe allergic reaction (anaphylaxis) - Hormone‑dependent tumor growth (rare)

Before prescribing Jaydess, clinicians should consider several safety measures.

Screen for pregnancy: product is contraindicated in confirmed or suspected pregnancy (Category X). Assess uterine position: ensure appropriate placement and uterine size. Monitor for infection: watch for signs of pelvic infection after insertion. Check for uterine abnormalities: avoid in bicornuate or septate uterus. Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel released from an intrauterine system can be affected by certain medications that alter hormone metabolism.

Major Interactions (Avoid): - Rifampin or other strong enzyme inducers: may reduce levonorgestrel effectiveness. - Certain antiepileptic drugs (e.g., carbamazepine, phenytoin): can lower hormone levels. - St. John's wort: may decrease contraceptive efficacy.

Moderate Interactions (Monitor Closely): - Antiretroviral agents (e.g., efavirenz): may modestly reduce hormone exposure. - Antifungal azoles (e.g., ketoconazole): could increase levonorgestrel levels. - Herbal supplements affecting CYP3A4: monitor for breakthrough bleeding.